Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alfonso Cristaudo

Showing results (41-50 of 73) with videos related to

Pageof 8
Sort By:
Plos One|June 23, 2017
Correction: MSLN gene silencing has an anti-malignant effect on cell lines overexpressing mesothelin deriving from malignant pleural mesotheliomaOmbretta Melaiu, Justin Stebbing, Ylenia Lombardo, et al.
Thyroid : Official Journal of the American Thyroid Association|September 26, 2008
Thyroid function and exposure to styreneFerruccio Santini, Alberto Mantovani, Alfonso Cristaudo, et al.
Eupa Open Proteomics|June 15, 2018
Comparative proteomic analysis of malignant pleural mesothelioma: Focusing on the biphasic subtypeLaura Giusti, Federica Ciregia, Alessandra Bonotti, et al.
Seminars in Cancer Biology|June 23, 2020
Primary cell cultures for the personalized therapy in aggressive thyroid cancer of follicular originPoupak Fallahi, Silvia Martina Ferrari, Giusy Elia, et al.
Cancer Genomics & Proteomics|April 30, 2020
Putative Biomarkers for Malignant Pleural Mesothelioma Suggested by Proteomic Analysis of Cell SecretomeSerena Lacerenza, Federica Ciregia, Laura Giusti, et al.
The International Journal of Biological Markers|September 21, 2016
Serum mesothelin, osteopontin and vimentin: useful markers for clinical monitoring of malignant pleural mesotheliomaAlessandra Bonotti, Silvia Simonini, Elena Pantani, et al.
International Journal of Cancer|June 12, 2013
TPO genetic variants and risk of differentiated thyroid carcinoma in two European populationsMonica Cipollini, Susana Pastor, Federica Gemignani, et al.
Best Practice & Research. Clinical Endocrinology & Metabolism|February 29, 2020
Graves' disease: Epidemiology, genetic and environmental risk factors and virusesAlessandro Antonelli, Silvia Martina Ferrari, Francesca Ragusa, et al.
BMC Cancer|March 18, 2016
Runs of homozygosity and inbreeding in thyroid cancerHauke Thomsen, Bowang Chen, Gisella Figlioli, et al.
Thyroid : Official Journal of the American Thyroid Association|April 2, 2020
Polymorphisms Within the <i>RET</i> Proto-Oncogene and Risk of Sporadic Medullary Thyroid CarcinomaFederica Gemignani, Cristina Romei, Raffaele Ciampi, et al.
Pageof 8

Showing results (41-50 of 73) with videos related to

Sort By:
Pageof 8
Plos One|June 23, 2017
Correction: MSLN gene silencing has an anti-malignant effect on cell lines overexpressing mesothelin deriving from malignant pleural mesotheliomaOmbretta Melaiu, Justin Stebbing, Ylenia Lombardo, et al.
Thyroid : Official Journal of the American Thyroid Association|September 26, 2008
Thyroid function and exposure to styreneFerruccio Santini, Alberto Mantovani, Alfonso Cristaudo, et al.
Eupa Open Proteomics|June 15, 2018
Comparative proteomic analysis of malignant pleural mesothelioma: Focusing on the biphasic subtypeLaura Giusti, Federica Ciregia, Alessandra Bonotti, et al.
Seminars in Cancer Biology|June 23, 2020
Primary cell cultures for the personalized therapy in aggressive thyroid cancer of follicular originPoupak Fallahi, Silvia Martina Ferrari, Giusy Elia, et al.
Cancer Genomics & Proteomics|April 30, 2020
Putative Biomarkers for Malignant Pleural Mesothelioma Suggested by Proteomic Analysis of Cell SecretomeSerena Lacerenza, Federica Ciregia, Laura Giusti, et al.
The International Journal of Biological Markers|September 21, 2016
Serum mesothelin, osteopontin and vimentin: useful markers for clinical monitoring of malignant pleural mesotheliomaAlessandra Bonotti, Silvia Simonini, Elena Pantani, et al.
International Journal of Cancer|June 12, 2013
TPO genetic variants and risk of differentiated thyroid carcinoma in two European populationsMonica Cipollini, Susana Pastor, Federica Gemignani, et al.
Best Practice & Research. Clinical Endocrinology & Metabolism|February 29, 2020
Graves' disease: Epidemiology, genetic and environmental risk factors and virusesAlessandro Antonelli, Silvia Martina Ferrari, Francesca Ragusa, et al.
BMC Cancer|March 18, 2016
Runs of homozygosity and inbreeding in thyroid cancerHauke Thomsen, Bowang Chen, Gisella Figlioli, et al.
Thyroid : Official Journal of the American Thyroid Association|April 2, 2020
Polymorphisms Within the <i>RET</i> Proto-Oncogene and Risk of Sporadic Medullary Thyroid CarcinomaFederica Gemignani, Cristina Romei, Raffaele Ciampi, et al.
Pageof 8